Rhenium Perrhenate (¹⁸⁸ReO₄) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells

Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a crucial challenge. Despite the promising progress in advanced targeted therapies, HCC is the fourth leading cause of cancer death worldwide. Radionuclide therapy can potentially be a practical targeted approach to addres...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Samieh Asadian, Abbas Piryaei, Nematollah Gheibi, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Mehdi Azad, Valentina Kapustina, Mehdi Alikhani, Sahar Moghbeli Nejad, Hani Keshavarz Alikhani, Morteza Mohamadi, Anastasia Shpichka, Peter Timashev, Moustapha Hassan, Massoud Vosough
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	hepatocellular carcinoma apoptosis induction cell cycle arrest Rhenium-188 (<sup>188</sup>Re) radionuclide therapy
Online Access:	https://www.mdpi.com/2073-4409/11/2/305